SEC Form 4 · accession 0001127602-15-007911
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 20, 2015
Accepted (ET)
Feb 24, 2015 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2015 | M | 70,229 | $58.58 | A | 413,193 | D | |
| Common Stock | Feb 20, 2015 | S | 70,229 | $75.00 | D | 342,964 | D | |
| Common Stock | Feb 22, 2015 | F | 2,869 | $76.18 | D | 340,095 | D | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $58.58 | Feb 20, 2015 | M | 70,229 | D | Feb 28, 2009 | Feb 28, 2015 | Common Stock | 70,229 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.